Valspar Corp. (VAL) Financials Nov 18, 2014, 11:43
Valspar Corp. (VAL) Financials Nov 18, 2014, 11:43 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Valspar Corp.
Fiscal year is November-October. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.88B 3.23B 3.95B 4.02B 4.1B
Cost of Goods Sold (COGS) incl. D&A 1.89B 2.14B 2.7B 2.65B 2.72B
COGS excluding D&A 1.8B 2.06B 2.6B 2.56B 2.64B
Depreciation & Amortization Expense 82.86M 81.31M 97.75M 93.7M 88.16M
Depreciation 75.29M 74.04M 90.11M 87.15M 81.12M
Amortization of Intangibles 7.58M 7.27M 7.64M 6.55M 7.04M
Gross Income 993.63M 1.08B 1.26B 1.37B 1.38B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 674.11M 695.74M 853.28M 861.79M 834.87M
Research & Development 91.3M 100.24M 115.42M 117.11M 116.04M
Other SG&A 582.81M 595.5M 737.87M 744.68M 718.83M
Other Operating Expense 0 0 0 0 0
Unusual Expense 30.92M 12M 442.98M 24.63M 54.34M
EBIT after Unusual Expense (30.92M) (12M) (442.98M) (24.63M) (54.34M)
Non Operating Income/Expense (3.28M) 1.21M (1.58M) 2.12M (4.01M)
Non-Operating Interest Income 0 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 47M 58.48M 62.69M 68.39M 63.48M
Gross Interest Expense 47M 58.48M 62.69M 68.39M 63.48M
Interest Capitalized 0 0 0 0 0
Pretax Income 238.33M 319.2M (103.15M) 417.22M 423.8M
Income Tax 78.18M 97.14M 35.45M 124.73M 134.54M
Income Tax - Current Domestic 37.72M 49.76M 46.08M 74.65M 115.25M
Income Tax - Current Foreign 22.06M 44.14M 25.28M 37.75M 32.03M
Income Tax - Deferred Domestic 15.19M 2.21M (23.5M) 18.16M (13.08M)
Income Tax - Deferred Foreign 3.2M 1.03M (12.4M) (5.84M) 341,000
Income Tax Credits 0 0 0 - 0
Equity in Affiliates 0 0 0 - 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 160.15M 222.06M (138.6M) 292.5M 289.26M
Minority Interest Expense 0 0 0 0 0
Net Income 160.15M 222.06M (138.6M) 292.5M 289.26M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 160.15M 222.06M (138.6M) 292.5M 289.26M
Preferred Dividends 9.95M 0 0 0 0
Net Income Available to Common 150.2M 222.06M (138.6M) 292.5M 289.26M
EPS (Basic) 1.50 2.25 (1.47) 3.20 3.29
Basic Shares Outstanding 100.04M 98.52M 94.31M 91.42M 87.79M
EPS (Diluted) 1.49 2.20 (1.47) 3.10 3.20
Diluted Shares Outstanding 100.92M 100.87M 94.31M 94.38M 90.53M
EBITDA 402.39M 469.77M 501.83M 601.82M 633.78M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...
Continue Reading
Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...
Continue Reading
A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...
Continue Reading
Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...
Continue Reading
Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...
Continue Reading
A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...
Continue Reading
Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...
Continue Reading
By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...
Continue Reading
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...
Continue Reading